Evaluation of a Single Intra‐Articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in a Canine Population

Abstract

APS injection reduced pain and lameness scores and increased weight-bearing associated with the OA-affected joint in dogs at 12 weeks providing preliminary evidence that APS therapy may be beneficial in the treatment of OA in dogs and supporting pursuit of additional studies.